In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes

被引:55
|
作者
Shaldam, Moataz A. [1 ]
Yahya, Galal [2 ,3 ]
Mohamed, Nashwa H. [4 ]
Abdel-Daim, Mohamed M. [5 ,6 ]
Al Naggar, Yahya [7 ,8 ]
机构
[1] Kafr EL Sheikh Univ, Fac Pharm, Dept Pharmaceut Chem, Kafr Al Sheikh 33516, Egypt
[2] Zagazig Univ, Fac Pharm, Microbiol & Immunol Dept, Al Sharqia 44519, Egypt
[3] Tech Univ Kaiserslautern, Fac Biol, Dept Mol Genet, Paul Ehrlich Str 24, D-67663 Kaiserslautern, Germany
[4] Hosp Zagazig Univ, Al Sharqia, Egypt
[5] King Saud Univ, Coll Sci, Dept Zool, POB 2455, Riyadh 11451, Saudi Arabia
[6] Suez Canal Univ, Fac Vet Med, Pharmacol Dept, Ismailia 41522, Egypt
[7] Tanta Univ, Fac Sci, Zool Dept, Tanta 31527, Egypt
[8] Martin Luther Univ Halle Wittenberg, Inst Biol, Gen Zool, Hoher Weg 8, D-06120 Halle, Saale, Germany
关键词
COVID-19; Honeybee products; Phenolic compounds; Molecular docking; Drug repurposing; Natural products; INHIBITORS; PHYTOCHEMICALS; DISCOVERY;
D O I
10.1007/s11356-021-14195-9
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
After the early advent of the Coronavirus Disease 2019 (COVID-19) pandemic, myriads of FDA-approved drugs have been massively repurposed for COVID-19 treatment based on molecular docking against selected protein targets that play fundamental roles in the replication cycle of the novel coronavirus. Honeybee products are well known of their nutritional values and medicinal effects. Bee products contain bioactive compounds in the form of a collection of phenolic acids, flavonoids, and terpenes of natural origin that display wide spectrum antiviral effects. We revealed by molecular docking the profound binding affinity of 14 selected phenolics and terpenes present in honey and propolis (bees glue) against the main protease (M-pro) and RNA-dependent RNA polymerase (RdRp) enzymes of the novel SARS-CoV-2 virus (the causative agent of COVID-19) using AutoDock Vina software. Of these compounds, p-coumaric acid, ellagic acid, kaempferol, and quercetin have the strongest interaction with the SARS-CoV-2 target enzymes, and it may be considered an effective COVID-19 inhibitor.
引用
收藏
页码:40507 / 40514
页数:8
相关论文
共 50 条
  • [41] Ayurvedic Medicinal Plants Against COVID-19: An In Silico Analysis
    Khuntia, Bharat Krushna
    Sharma, Vandna
    Qazi, Sahar
    Das, Soumi
    Sharma, Shruti
    Raza, Khalid
    Sharma, Gautam
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (11)
  • [42] Molecules against COVID-19: An in Silico Approach for Drug Development
    Rhythm Bharti
    Sandeep Kumar Shukla
    JournalofElectronicScienceandTechnology, 2021, 19 (01) : 14 - 24
  • [43] Molecules against COVID-19: An in Silico Approach for Drug Development
    Bharti R.
    Shukla S.K.
    Journal of Electronic Science and Technology, 2021, 19 (01) : 14 - 24
  • [44] In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism
    Quah, Yixian
    Lee, Yuan Yee
    Lee, Seung-Jin
    Kim, Sung Dae
    Rhee, Man Hee
    Park, Seung-Chun
    JOURNAL OF GINSENG RESEARCH, 2023, 47 (02) : 283 - 290
  • [45] In silico analysis of natural products from Brazilian biodiversity in COVID-19 treatment: NuBBEDB against SARSCoV2 PLpro
    de Araujo Ribas Cheohen, Caio Felipe
    Allonso, Diego
    da Silva, Manuela Leal
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1456 - 1456
  • [46] In Silico Exploration of CD200 as a Therapeutic Target for COVID-19
    Perovic, Vladimir
    Glisic, Sanja
    Veljkovic, Milena
    Paessler, Slobodan
    Veljkovic, Veljko
    MICROORGANISMS, 2024, 12 (06)
  • [47] A Review of the Role of Micronutrients and Bioactive Compounds on Immune System Supporting to Fight against the COVID-19 Disease
    Camara, Montana
    Sanchez-Mata, Maria Cortes
    Fernandez-Ruiz, Virginia
    Camara, Rosa Maria
    Cebadera, Elena
    Dominguez, Laura
    FOODS, 2021, 10 (05)
  • [48] Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
    Xu, Haiyu
    Li, Shufen
    Liu, Jiayuan
    Cheng, Jinlong
    Kang, Liping
    Li, Weijie
    Zhong, Yute
    Wei, Chaofa
    Fu, Lifeng
    Qi, Jianxun
    Zhang, Yulan
    You, Miaomiao
    Zhou, Zhenxing
    Zhang, Chongtao
    Su, Haixia
    Yao, Sheng
    Zhou, Zhaoyin
    Shi, Yulong
    Deng, Ran
    Lv, Qi
    Li, Fengdi
    Qi, Feifei
    Chen, Jie
    Zhang, Siqin
    Ma, Xiaojing
    Xu, Zhijian
    Li, Shao
    Xu, Yechun
    Peng, Ke
    Shi, Yi
    Jiang, Hualiang
    Gao, George F.
    Huang, Luqi
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (18)
  • [49] In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach
    Chandel, Vaishali
    Raj, Sibi
    Rathi, Brijesh
    Kumar, Dhruv
    CHEMICAL BIOLOGY LETTERS, 2020, 7 (03): : 166 - 175
  • [50] Products in a Pandemic: Liability for Medical Products and the Fight against COVID-19
    Fairgrieve, Duncan
    Feldschreiber, Peter
    Howells, Geraint
    Pilgerstorfer, Marcus
    EUROPEAN JOURNAL OF RISK REGULATION, 2020, 11 (03) : 565 - 603